Spyre Therapeutics Inc (SYRE)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -41.049 | -44.236 | -66.282 | -97.257 | -66.089 | -48.464 | -92.577 | -164.062 |
| Return on Equity (%) | -106.47 | -48.076 | -75.316 | -122.743 | -80.928 | -58.81 | -124.868 | -289.167 |
| Return on Invested Capital (%) | -107.649 | -48.971 | -77.395 | -127.536 | -82.895 | -59.792 | -130.079 | -163.595 |
| Operating Margin (%) | -468.842 | -523.266 | -1140.638 | N/A | N/A | -350.392 | -3604.594 | -38241.084 |
| Net Profit Margin (%) | -468.842 | -523.266 | -1140.638 | N/A | N/A | -351.145 | -3598.755 | -38238.149 |
| Book Value Per Share | 2.81 | 1.963 | 2.036 | 1.579 | 2.456 | 1.439 | 0.714 | 20.624 |
| Earnings Per Share | -0.968 | -1.062 | -1.339 | -2.056 | -1.421 | -1.128 | -1.189 | -26.017 |
| Cash Per Share | 2.131 | 0.5 | 0.678 | 0.506 | 1.583 | 0.26 | 0.495 | 14.506 |
| Working Capital Per Share | 2.788 | 1.925 | 2.006 | 1.475 | 2.342 | 1.35 | 0.675 | 23.771 |
| Operating Profit Per Share | 0.207 | 0.203 | 0.117 | N/A | N/A | 0.321 | 0.033 | 0.068 |
| EBIT Per Share | -0.968 | -1.062 | -1.339 | -2.056 | -1.421 | -1.126 | -1.191 | -26.019 |
| EBITDA Per Share | -0.968 | -1.062 | -1.339 | -2.056 | -1.421 | -1.126 | -1.191 | -26.019 |
| Free Cash Flow Per Share | -0.965 | -1.048 | -1.335 | -2.028 | -1.363 | -1.145 | -1.208 | -26.074 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 13.43M | 16.67M | 24.14M | 29.08M | 47.96M | 49.36M | N/A | N/A |
| Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 61.51M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | -9322.222 | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | -9304.04 | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 1.73B |
| Price to Earnings Ratio | -5.09 |
| Price to Sales Ratio | 1.95k |
| Price to Cash Ratio | 9.14 |
| Price to Book Ratio | 6.43 |
| Dividend Yield | - |
| Shares Outstanding | 50.79M |
| Average Volume (1 week) | 310.4k |
| Average Volume (1 Month) | 385.38k |
| 52 Week Change | 209.71% |
| 52 Week High | 47.97 |
| 52 Week Low | 10.42 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
